|
1
|
Amin A, Shriver CD, Henry LR, Lenington S,
Peoples GE and Stojadinovic A: Breast cancer screening compliance
among young women in a free access healthcare system. J Surg Oncol.
97:20–24. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Ward EM, Johnson CJ, Cronin KA,
Ma J, Ryerson B, Mariotto A, Lake AJ, Wilson R, Sherman RL, et al:
Annual report to the Nation on the status of cancer, 1975–2014,
featuring survival. J Natl Cancer Inst. 109:2017. View Article : Google Scholar
|
|
3
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: Are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fu Y and Cao F: MicroRNA-125a-5p regulates
cancer cell proliferation and migration through NAIF1 in prostate
carcinoma. Onco Targets Ther. 8:3827–3835. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Guo X, Wu Y and Hartley RS: MicroRNA-125a
represses cell growth by targeting HuR in breast cancer. RNA Biol.
6:575–583. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cai M, Chen Q, Shen J, Lv C and Cai L:
Epigenetic silenced miR-125a-5p could be self-activated through
targeting Suv39H1 in gastric cancer. J Cell Mol Med. 22:4721–4731.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang WK, Akçakaya P, Gangaev A, Lee L,
Zeljic K, Hajeri P, Berglund E, Ghaderi M, Åhlén J, Bränström R, et
al: miR-125a-5p regulation increases phosphorylation of FAK that
contributes to imatinib resistance in gastrointestinal stromal
tumors. Exp Cell Res. 371:287–296. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang X, Jin T, Huang X, Liu X, Liu Z, Jia
Y and Hao J: Effects of the tumor suppressor PTEN on biological
behaviors of activated pancreatic stellate cells in pancreatic
fibrosis. Exp Cell Res. 373:132–144. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dong Q, Yang B, Han JG, Zhang MM, Liu W,
Zhang X, Yu HL, Liu ZG, Zhang SH, Li T, et al: A novel hydrogen
sulfide-releasing donor, HA-ADT, suppresses the growth of human
breast cancer cells through inhibiting the PI3K/AKT/mTOR and
Ras/Raf/MEK/ERK signaling pathways. Cancer Lett. 455:60–72. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liang Y, Ye J, Jiao J, Zhang J, Lu Y,
Zhang L, Wan D, Duan L, Wu Y and Zhang B: Down-regulation of
miR-125a-5p is associated with salivary adenoid cystic carcinoma
progression via targeting p38/JNK/ERK signal pathway. Am J Transl
Res. 9:1101–1113. 2017.PubMed/NCBI
|
|
11
|
Pan Q, Liao X, Liu H, Wang Y, Chen Y, Zhao
B, Lazartigues E, Yang Y and Ma X: MicroRNA-125a-5p alleviates the
deleterious effects of ox-LDL on multiple functions of human brain
microvessel endothelial cells. Am J Physiol Cell Physiol.
312:C119–C130. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kluck RM, Bossy-Wetzel E, Green DR and
Newmeyer DD: The release of cytochrome c from mitochondria: A
primary site for Bcl-2 regulation of apoptosis. Science.
275:1132–1136. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
de la Mare JA, Contu L, Hunter MC, Moyo B,
Sterrenberg JN, Dhanani KC, Mutsvunguma LZ and Edkins AL: Breast
cancer: Current developments in molecular approaches to diagnosis
and treatment. Recent Pat Anticancer Drug Discov. 9:153–175. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jafari SH, Saadatpour Z, Salmaninejad A,
Momeni F, Mokhtari M, Nahand JS, Rahmati M, Mirzaei H and Kianmehr
M: Breast cancer diagnosis: Imaging techniques and biochemical
markers. J Cell Physiol. 233:5200–5213. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
M Braden A, V Stankowski R, M Engel J and
A Onitilo A: Breast cancer biomarkers: Risk assessment, diagnosis,
prognosis, prediction of treatment efficacy and toxicity, and
recurrence. Curr Pharm Des. 20:4879–4898. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hsieh TH, Hsu CY, Tsai CF, Long CY, Chai
CY, Hou MF, Lee JN, Wu DC, Wang SC and Tsai EM: miR-125a-5p is a
prognostic biomarker that targets HDAC4 to suppress breast
tumorigenesis. Oncotarget. 6:494–509. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Scott GK, Goga A, Bhaumik D, Berger CE,
Sullivan CS and Benz CC: Coordinate suppression of ERBB2 and ERBB3
by enforced expression of micro-RNA miR-125a or miR-125b. J Biol
Chem. 282:1479–1486. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu X, Du L and Feng R: c-Src regulates
cell cycle proteins expression through protein kinase B/glycogen
synthase kinase 3 beta and extracellular signal-regulated kinases
1/2 pathways in MCF-7 cells. Acta Biochim Biophys Sin (Shanghai).
45:586–592. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jafari SM, Joshaghani HR, Panjehpour M and
Aghaei M: A2B adenosine receptor agonist induces cell cycle arrest
and apoptosis in breast cancer stem cells via ERK1/2
phosphorylation. Cell Oncol (Dordr). 41:61–72. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Düzgün ŞA, Yerlikaya A, Zeren S, Bayhan Z,
Okur E and Boyacı İ: Differential effects of p38 MAP kinase
inhibitors SB203580 and SB202190 on growth and migration of human
MDA-MB-231 cancer cell line. Cytotechnology. 69:711–724. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mashayekhi S, Yousefi B, Tohidi E, Darband
SG, Mirza-Aghazadeh-Attari M, Sadighparvar S, Kaviani M,
Shafiei-Irannejad V, Kafil HS, Karimian A, et al: Overexpression of
tensin homolog deleted on chromosome ten (PTEN) by ciglitazone
sensitizes doxorubicin-resistance leukemia cancer cells to
treatment. J Cell Biochem. 120:15719–15729. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ocana A, Vera-Badillo F, Al-Mubarak M,
Templeton AJ, Corrales-Sanchez V, Diez-Gonzalez L, Cuenca-Lopez MD,
Seruga B, Pandiella A and Amir E: Activation of the PI3K/mTOR/AKT
pathway and survival in solid tumors: Systematic review and
meta-analysis. PLoS One. 9:e952192014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xiong S, Cheng JC, Klausen C, Zhao J and
Leung PC: TGF-β1 stimulates migration of type II endometrial cancer
cells by down-regulating PTEN via activation of SMAD and ERK1/2
signaling pathways. Oncotarget. 7:61262–61272. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cho E, Chung EY, Jang HY, Hong OY, Chae
HS, Jeong YJ, Kim SY, Kim BS, Yoo DJ, Kim JS and Park KH:
Anti-cancer effect of cyanidin-3-glucoside from mulberry via
caspase-3 cleavage and DNA fragmentation in vitro and in vivo.
Anticancer Agents Med Chem. 17:1519–1525. 2017. View Article : Google Scholar : PubMed/NCBI
|
